Overall Technical outlook

Price Summary

On 2025-12-10, Sun Pharmaceutical Industries Limited's stock began at 1787.9, climbed to 1791.7, dropped to 1767.9, and had -0.13% to end at 1785.5, with a volume of 2321740 shares.
The peak price for the stock in the past 52 weeks is 1889.95, with the lowest price being 1563.3.
SUNPHARMA's future price is expected to lie between 1570.0 and 2450.0, with an average expectation of 1948.9736, as per the recommendations of 38 analysts.

Technicals

Support and Resistance: At 1785.5, the price is supported at 1777.4 and faces resistance at 1806.7. This range suggests that the price for SUNPHARMA might stay between these levels, with 1777.4 acting as a floor and 1806.7 as a ceiling.
SUNPHARMA supportResistance 479136
Support/Resistance for SUNPHARMA


Aroon: The AROON is in a neutral stance for SUNPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
SUNPHARMA aroon 479136
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for SUNPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
SUNPHARMA bbands 479136
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR continues to signal a bearish outlook, setting a significant resistance level. This resistance could limit upward momentum, indicating that the market may struggle to overcome this bearish pressure in the near term.
SUNPHARMA psar 479136
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
SUNPHARMA stoch 479136
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The 20, 50, and 100 moving averages are currently aligned bearishly, pointing to a downtrend. However, the slopes of the 20 and 50 SMAs are showing signs of wavering, suggesting that this bearish momentum may be weakening. This could indicate that a bullish reversal is imminent, with the market potentially shifting from its current downward trend to a more positive, upward trajectory.
SUNPHARMA trippleSMA 479136
Tripple SMA chart for Sun Pharmaceutical Industries Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.